Hyaluronic Acid Influences Amino Acid Metabolism via Differential L-Type Amino Acid Transporter 1 Expression in the U87-Malignant Glioma Cell Line

被引:0
|
作者
Bale, Ashwin A. [1 ]
Thammineni, Swaroop [2 ]
Bhargava, Rohit [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Harley, Brendan [1 ,3 ,7 ]
机构
[1] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61802 USA
[2] Univ Illinois, Dept Bioengn, Urbana, IL 61802 USA
[3] Univ Illinois, Canc Ctr Illinois, Urbana, IL 61802 USA
[4] Univ Illinois at Urbana Champaign, Beckman Inst Adv Sci Technol, Dept Elect & Comp Engn, Urbana, IL 61801 USA
[5] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mech Sci & Engn, Urbana, IL 61802 USA
[6] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Chem, Urbana, IL 61802 USA
[7] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61802 USA
基金
美国国家卫生研究院;
关键词
amino acids; glioblastomas; glucoses; hyaluronic acids; metabolisms; molecular weights; GROWTH-FACTOR; ADJUVANT TEMOZOLOMIDE; GLIOBLASTOMA CELLS; CANCER METABOLISM; OXIDATIVE STRESS; CARCINOMA; INVASION; GLUTAMATE; CYCLE; LAT1;
D O I
10.1002/anbr.202400107
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The glioblastoma (GBM) tumor microenvironment is heterogeneous, complex, and being increasingly understood as a significant contributor to tumor progression. In brain tumors, the extracellular matrix contains a large concentration of hyaluronic acid (HA) that makes it important to study its role in cancer progression. In particular, abnormal accumulation of HA is observed in gliomas and is often associated with poor prognosis. In addition, HA is a polymer and its molecular weight (MW) distribution may influence tumor cell activity. Herein, the influence of the MW of HA on tumor cell metabolism is evaluated. A 2D cell culture approach is used to expose the U87-MG (medium glucose [MG]) cell line to different HA MWs (10, 60, and 500 kDa) and glucose concentrations (0, 5.5, and 25 mm). Notably, it is found that HA influences GBM amino acid metabolism via reduction in LAT1 transporter protein expression. Also an influence on mitochondrial respiration levels and a difference in the accumulation of some key products of cell metabolic activity (lactic acid, glutamic acid, and succinic acid) are reported. Overall, in these results, it is indicated that HA MW can influence GBM metabolic state, with implications for cell invasion and tumor progression. Hyaluronic acid (HA) is a key component of brain's extracellular matrix and its abnormal accumulation is often linked with poor prognosis in cancers like glioblastoma. HA is a polymer, and its molecular weight distribution may influence tumor cell activity. In this manuscript, this influence specifically on tumor cell metabolism using a 2D cell culture approach is evaluated.image (c) 2024 WILEY-VCH GmbH
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Hyaluronic acid influences amino acid metabolism in glioblastoma's U87-MG cell line in a 2D culture via LAT1 transporter expression
    Bale, Ashwin A.
    Bhargava, Rohit
    Harley, Brendan
    CANCER RESEARCH, 2024, 84 (05)
  • [2] L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism
    Sato, Miku
    Harada-Shoji, Narumi
    Toyohara, Takafumi
    Soga, Tomoyoshi
    Itoh, Masatoshi
    Miyashita, Minoru
    Tada, Hiroshi
    Amari, Masakazu
    Anzai, Naohiko
    Furumoto, Shozo
    Abe, Takaaki
    Suzuki, Takashi
    Ishida, Takanori
    Sasano, Hironobu
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism
    Miku Sato
    Narumi Harada-Shoji
    Takafumi Toyohara
    Tomoyoshi Soga
    Masatoshi Itoh
    Minoru Miyashita
    Hiroshi Tada
    Masakazu Amari
    Naohiko Anzai
    Shozo Furumoto
    Takaaki Abe
    Takashi Suzuki
    Takanori Ishida
    Hironobu Sasano
    Scientific Reports, 11
  • [4] High expression of L-type amino acid transporter 1 in infiltrating glioma cells
    Nawashiro H.
    Otani N.
    Uozumi Y.
    Ooigawa H.
    Toyooka T.
    Suzuki T.
    Katoh H.
    Tsuzuki N.
    Ohnuki A.
    Shima K.
    Shinomiya N.
    Matsuo H.
    Kanai Y.
    Brain Tumor Pathology, 2005, 22 (2) : 89 - 91
  • [5] L-Type Amino Acid Transporter 1 (LAT1) Expression in Malignant Pleural Mesothelioma
    Kaira, Kyoichi
    Oriuchi, Noboru
    Takahashi, Toshiaki
    Nakagawa, Kazuo
    Ohde, Yasuhisa
    Okumura, Takehiro
    Murakami, Haruyasu
    Shukuya, Takehito
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kanai, Yoshikatsu
    Endo, Masahiro
    Kondo, Haruhiko
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    ANTICANCER RESEARCH, 2011, 31 (12) : 4075 - 4082
  • [6] Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells
    Kobayashi, Keiichi
    Ohnishi, Akiko
    Promsuk, Jutabha
    Shimizu, Saki
    Kanai, Yoshikatsu
    Shiokawa, Yoshiaki
    Nagane, Motoo
    NEUROSURGERY, 2008, 62 (02) : 493 - 503
  • [7] Expression of L-type amino acid transporter 1 in various skin lesions
    Hirano, Kazuhiko
    Uno, Kaname
    Kuwabara, Haruki
    Kojima, Kaoruko
    Ohno, Shin-ichiro
    Sakurai, Hiroyuki
    Kamma, Hiroshi
    Kurata, Atsushi
    PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (10) : 634 - 639
  • [8] Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells - Comments
    Vogelbaum, Michael A.
    Kuo, John S.
    Fusco, David J.
    Bruce, Jeffrey N.
    Matouk, Charles
    Rutka, James T.
    NEUROSURGERY, 2008, 62 (02) : 503 - 504
  • [9] Expression of L-type amino acid transporter 1 in canine and feline intracranial tumors
    Utsugi, Shinichi
    Ogihara, Kikumi
    Naya, Yuko
    Sunden, Yuji
    Nakamoto, Yuya
    Okamoto, Yoshiharu
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2022, 84 (08): : 1111 - 1117
  • [10] The L-type Amino Acid Transporter (LAT1) Expression in Patients with Scoliosis
    Demura, Satoru
    Hinoi, Eiichi
    Kawakami, Noriaki
    Handa, Makoto
    Yokogawa, Noriaki
    Hiraiwa, Manami
    Kato, Satoshi
    Shinmura, Kazuya
    Shimizu, Takaki
    Oku, Norihiro
    Annen, Ryohei
    Kobayashi, Motoya
    Yamada, Yohei
    Nagatani, Satoshi
    Iezaki, Takashi
    Taniguchi, Yuki
    Tsuchiya, Hiroyuki
    SPINE SURGERY AND RELATED RESEARCH, 2022, 6 (04): : 402 - 407